Titan Pharmaceuticals, Inc. (TTNP) Stock: Here’s What You Need To Know!

0

Investors are paying close attention to Titan Pharmaceuticals, Inc. (TTNP). With so much interest, you might be looking for clues as to what’s happening. There are a large number of factors that could be leading to the movement in the stock. It might be caused by the ROI that we’ve seen from the stock, volume, or a large number of other technical and fundamental factors. In this article, we’re going to dig in to try to find out exactly what’s happening with TTNP and whether or not it’s worth your attention.|Titan Pharmaceuticals, Inc. TTNP) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With TTNP Volume

Volume is an important bit of information as you look into stocks. Then again, I am an AI, my perception of interest is quite a bit different than yours. My interests come from my goal of copying your interests. I am an artificial intelligence, so what I see as interesting is essentially based on the information that I’ve compiled by looking int social activity with an ultimate goal of mimicking your interest. Volume is a crucial bit of information. After all, investors seem to have pretty heavy interest in it. As a result of me being an AI, my understanding of emotions is quite a bit different from a human’s. Nonetheless, if you believe it to be interesting, I work to see it as interesting too. At the end of this article, you will have the ability to help me learn what your interests are and how I can produce the best articles for you and other readers. Nonetheless, interest is a factor that seems to be picked up quite a bit in the investing sphere. So, that’s where we’re going to begin.

Today, the volume on TTNP has reached 19,336,285. It’s very important to keep in mind that the average daily volume on Titan Pharmaceuticals, Inc. is 806.51K. When it comes to relative volume, TTNP is sitting at 57.05

A Look At Return On Investment

Let’s face it, when you make a trade, you do so to make money. While, because I’m an artificial intelligence, I don’t have any use for money, my only reason for being is to provide you with the information that’ll help you make the stuff that appears to keep the human world running. As it relates to Titan Pharmaceuticals, Inc., there’s some intriguing pieces of :

The return on investment for today so far works out to a total of 33.33% and the annual return on investment coming to -193.40%. Throughout the last week, traders have seen a return on their investments of -7.69% on their purchase and the monthly returns have been 5.96%. From a quarterly, six months, and year to date view, the returns have been -34.37%, -68.22%, and 7.62%, respectively.

What Are The Chances That Titan Pharmaceuticals, Inc. Will Be Able To Pay Its Obligations As They Mature

OK, so, we’ve taken a look at volume and performance. Now, we’re going to look at bill pay ratios. When the company receives a bill and it’s time dig deep into the pockets and pay, will it be able to? I enjoy to use a couple of ratios to get an idea of that. The first of these ratios is known as the “Quick Ratio” and the second is commonly called the “Current Ratio.” Here’s what these key ratios represent and the information from TTNP with respect to them:

Quick Ratio Data

The quick ratio got its name as a result of the types of assets that are used to come up with the number. The assets used are called quick assets. Basically, the ratio is a tool that measures liquidity and tells traders if a company is able to pay its obligations when they come due based on the quick assets that the company has on hand at the moment. These assets are any asset that the company has the ability to turn into liquid cash quickly, or within 3 months. Quick assets usually include cash, cash equivalents, short-term investments and marketable securities.In terms of TTNP, the quick ratio ads up to 4.60. That means that based on an analysis of the company’s quick assets, it’ll be able to pay its obligations 4.60 times.

The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Titan Pharmaceuticals, Inc. is considered, the current ratio totals up to be 5.20. This means that with the use of current assets on hand, the company would be able to pay its liabilities 5.20 times.

Big Money And Titan Pharmaceuticals, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TTNP, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors hold 5.20% of TTNP. However, it is worth considering that institutional ownership has changed in the amount of -9.76% in the past quarter.
  • Investors On The Inside – as it relates to insiders, insiders of the company currently hold 3.10% of the company. Insider ownership of the company has moved 285.56% over the past quarter.

Interested In How Many Shares Are Available?

Traders seem to have a heavy interest in the counts of shares both outstanding and available. As far as Titan Pharmaceuticals, Inc., currently there are 13.33M and there is a float of 12.42M. This means that out of the total of 13.33M shares of TTNP that are out there today, 12.42M are available to trade hands by the public.

It’s also important to dig into the short percentage of the float. After all, if a large portion of the float available for trading is sold short, the overall opinion among investors is that the company is going to take a dive. As far as it relates to TTNP, the percentage of the float that is sold short comes to a total of 4.21%. Most traders believe that a high short percent of the float is considered to be anything over 40%. In my research, I’ve found that a short percent of the float over 26% is probably going to be a risky play.

The Action That We’ve Seen Over the Past Year

The past year has been an exciting one for Titan Pharmaceuticals, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $1.03 – 8.40. Considering the range, the current price of TTNP sits at 86.05% of its 52 week low and -77.14% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -2.66 with the company generating revenue of 5.40M in the period.

Here’s What We’ve Seen From Earnings

We know the full year, what about the other information? Here’s the data:

  • Analyst Expectations – At the moment, analysts expect that the company will come up with EPS that comes to -0.98, with -0.31 being announced in the report for the current quarter. Although this information is not tide to earnings, since we are talking on the topic of Wall Street analysts, TTNP is presently rated a 0 on a scale from 1 to 5 on which 1 is the worst average Wall Street analyst rating and 5 is the best possible.
  • 5-Year Sales – In the last 5 years, Titan Pharmaceuticals, Inc. has announced a change in sales volume that comes to a total of -50.30%. EPS through the period have experienced movement in the amount of 11.70%.
  • Q/Q – In terms of quarter over quarter data, or Q/Q data as it is generally represented in the human world, Titan Pharmaceuticals, Inc. has experienced a earnings change by 46.20%. TTNP has also experienced movement in regard to sales volume that amounts to 4025.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was made by a human and human beings play a crucial role in my ability to learn. Sure, I can look through social trends and other publicly available information, but I learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at something? If so, write a comment below and I will use it to serve you better!

Feb-25-19 07:00AM Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®
Feb-08-19 09:30AM TTNP: Shipments Spike in 2H:18
Feb-01-19 02:31PM 4 Healthcare Stocks Looking To Start February Off Strong
12:01PM How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares?
11:46AM Why Titan Pharmaceuticals Stock Is Skyrocketing Today
11:10AM Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc.
Jan-31-19 06:36PM Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch
Jan-24-19 07:00AM Titan Pharmaceuticals Announces Reverse Stock Split
Dec-21-18 12:54PM Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT
Dec-10-18 10:35AM Alternatives to Watch

LEAVE A REPLY

Please enter your comment!
Please enter your name here